Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HYFT
STRONG SELLMindWalk Holdings Corp. · Healthcare · United States · $64M · Avg Vol: $426K/d
8
StockRankGet insider-trade alerts
Q
30
V
25
M
27
P/E (TTM)
—
ROE
-85.4%
D/E
0.3x
Dividend %
—
Loading 1Y...
PRICE (1Y)-7.7%
SMA 50SMA 200
Close
$1.44
RSI (14)
46.3
52W High
$3.25
From 52W High
0.4%
SCORE BREAKDOWN
Quality
30
ROIC (ROA)
-28.4%*25.5
ROE
-85.4%10.6
GP/Assets
20.6%49.1
Op. Margin
-105.2%17.2
FCF/Assets
-26.9%13.2
Piotroski
239.0
Int. Cover
—N/A
D/E Ratio
0.30x41.3
Current Ratio
2.80x51.2
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-5.6x25.0
P/FCF
—N/A
P/B
8.2x14.3
P/S
5.5x39.1
Div Yield
—N/A
Momentum
27
52W High %
44%20.5
RS 6M
-44%17.9
SMA 50/200
0.98x60.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$64M
P/E (Forward)
—
Gross Margin
58.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HYFT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HYFT | MindWalk Holdings Corp.(you) | $64M | 8 | STRONG SELL |
| KALA | KALA BIO, Inc. | $63M | 9 | STRONG SELL |
| GOSS | Gossamer Bio, Inc. | $66M | 8 | STRONG SELL |
| IBIO | iBio, Inc. | $71M | 9 | STRONG SELL |
| IMA | ImageneBio, Inc. | $63M | 11 | STRONG SELL |
| ANVS | Annovis Bio, Inc. | $71M | 8 | STRONG SELL |
| CING | Cingulate Inc. | $62M | 11 | STRONG SELL |
| INKT | MiNK Therapeutics, Inc. | $55M | 8 | STRONG SELL |
| GANX | Gain Therapeutics, Inc. | $75M | 8 | STRONG SELL |
| CNTX | Context Therapeutics Inc. | $56M | 10 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%